Skip to content

A multi-center randomized controlled clinical trial for standardized respiratory support treatment for acute severe virus pneumonia

A multi-center randomized controlled clinical trial for standardized respiratory support treatment for acute severe virus pneumonia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020826
Enrollment
Unknown
Registered
2019-01-20
Start date
2018-12-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virus pneumonia

Interventions

Group 2:non-invasive mechanical ventilation

Sponsors

The First Afilliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged >18 years; 2. Diagnosed as acute viral pneumonia, diagnose criteria: (1) Clinical manifestations: fever, cough, headache, muscle pain, or epidemiological history; (2) The pathogen specimen was positive: any one kind of respiratory specimen (nasopharyngeal secretions, sputum, endotracheal aspiration, BALF) is positive: ? nucleic acid of virus; ? virus antigen; ? the virus was isolated from respiratory specimen; ? dynamic detetion of acute phase and recovery phase of serum, virus specific antibody level was 4 times or more increased; 3. Meet one of the following conditions: (1) 150mmHg < P/F < 300mmHg or temporarily do not meet the indications of invasive mechanical ventilation; Detection conditions for arterial blood gas analysis: non-invasive positive pressure ventilation, CPAP mode, CPAP=5cmH2O, adjusting FiO2, and maintaining SPO2 at 88% to 92% for 30 minutes; (2) Patients with initial P/F =150 mmHg, temporary no indications of emergency tracheal intubation, noninvasive positive pressure ventilation support first (based on the experience of doctors set model and parameters, maintaining SPO2 at 88% to 92%) for 4 h, then get arterial blood gas analysis under the condition of CPAP=5cmH2O, 150mmHg < P/F =300mmHg.

Exclusion criteria

Exclusion criteria: 1. Received invasive mechanical ventilation; 2. Underlying diseases and complications: (1) Hypercapnia; (2) Acute attack of bronchial asthma; (3) Acute exacerbation of chronic respiratory failure caused by COPD or other chronic lung diseases; (4) Cardiogenic pulmonary edema; (5) Severe neutropenia (neutrophil < 0.5x10^9 /L); (6) Hemodynamic instability (systolic blood pressure < 90 mmHg or mean arterial pressure < 65 mmHg, vasopressors should be used); (7) GCS score=12; (8) Contraindications to noninvasive ventilation; (9) Indications of emergency endotracheal intubation (evaluated by clinicians); (10) Facial deformities, nasal deformities or diseases cannot receive nasal mask, mask and nasal catheter; (11) Conditions requiring airway protection, such as seizure and massive hemoptysis; 3. Tracheotomy; 4. Refuse endotracheal intubation; 5. Pregnant women.

Design outcomes

Primary

MeasureTime frame
intubation rate;

Secondary

MeasureTime frame
time to intubation;

Countries

China

Contacts

Public ContactLiu Xiaoqing

The First Afilliated Hospital of Guangzhou Medical University

lxq1118@126.com+86 13602769670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026